Kafrelsheikh faculty of medicine
Kafr ash Shaykh, Kafrelsheikh, Egypt
NCT Number: NCT04345835
prone flexed position in percutanous nephrolithotomy in comparsion with standard prone position. A randomized controlled trial.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Kafr ash Shaykh, Kafrelsheikh, Egypt
Patients meeting the inclusion criteria will be randomly allocated to 2 groups:
III. Recruitment of participants Patients appointed for an outpatient diagnostic cystoscopy will be reviewed for the inclusion and exclusion criteria. Legible patients will be asked to participate in the study and to sign the informed consent form.
IV. Randomisation Randomization will be performed using computer generated random tables using stratified blocked randomization in 1:1 ratio.
V. Study procedure Preoperative evaluations included
Operative Technique
Prone-flexed positioning i. Retrograde access will be obtained ii. The patient is repositioned prone with adequate padding under the pressure points of the head, chest, knees, and feet.
iii. The table is flexed 30 degrees at the level of the patient's mid lumbar region to open the space between the 12th rib and the posterior iliac crest dropping the gluteal muscles from the working plane.
Ancillary intervention
Patients will receive a 20-mL infiltration of 0.25% bupivacaine. Under fluoroscopic guidance, the local analgesic was infiltrated with a 22-gauge spinal needle (10-cm length) along the nephrostomy tract at the 3, 6, 9, and 12 o'clock positions (5 mL in each tract), including the muscles, subcutaneous tissue, and skin.
Patients will receive 1 g tranexamic acid at induction followed by three further doses of 500 mg over the next 24 h.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
different procedure positioning
Other names: PNL
Time frame: end of the study
Comparing the prone with the prone-flexed position for PCNL reporting complications using the Clavien-Dindo system
Time frame: end of the study
Comparison of the Guy's (19)" combines the number of stones, their location, and abnormal patient anatomy into a score 1-4", S.T.O.N.E. (20)"uses the stone size, tract length, obstruction, number of calyces involved, and stone density from patient's preoperative CT scan", and CROES (21) "a continuous variable calculated by stone characteristics, patient data, and surgeon/centre experience" Scores for predicting outcomes following PCNL
Time frame: end of the study
Explore the relationship between stone density using various HU values "highest HU value (HUmax), lowest HU value (HUmin) and average HU value (HUave)"on and outcomes of percutaneous nephrolithotomy (PCNL)
Time frame: end of the study
Assess the impact of the ellipsoid volume of the stone [volume = π/6*(AP*H*CC)] after measuring the antero-posterior and horizontal dimensions in the axial images and the cranio-caudal dimension in the coronal images on and outcomes of percutaneous nephrolithotomy (PCNL).
Time frame: end of the study
Investigate the effect of antifibrinolytic tranexamic acid usage on blood loss during PCNL.
Kafrelsheikh University
Other
Prone Flexed Position in Percutanous Nephrolithotomy in Comparsion With Standard Prone Position. A Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06615713
Calculi, Female Urogenital Diseases
Nadiād, India
View Trial DetailsNCT07522619
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Karachi, Sindh, Pakistan
View Trial DetailsNCT07464717
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Peshawar, KhyberPakhtunkhwa, Pakistan
View Trial DetailsNCT07360041
Calculi, Calculus
Cairo, Cairo Governorate, Egypt
View Trial Details